Literature DB >> 3882924

Pharmacokinetics of quinine in children.

F Shann, J Stace, M Edstein.   

Abstract

Serum quinine concentrations were measured in seven children after intravenous infusion of quinine dihydrochloride, in eight children after intramuscular injection of quinine dihydrochloride, and in six children after nasogastric administration of a solution of quinine dihydrochloride. The mean (+/- SD) half-life of quinine was 11.1 +/- 4.8 hours, and the volume of distribution was 1.39 +/- 0.37 L/kg. To attain a serum level of 10 microgram/ml quinine, we suggest that children with severe malaria be given a loading dose of 20 mg/kg quinine dihydrochloride parenterally, followed by 7.5 mg/kg every 8 hours. Once recovery begins, quinine sulphate 10 mg/kg may be given orally every 8 hours. Serum concentrations should be monitored, if possible, because they vary greatly from person to person. Quinine is rapidly and completely absorbed after either intramuscular or nasogastric administration.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3882924     DOI: 10.1016/s0022-3476(85)80692-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  19 in total

1.  Population pharmacokinetics of intramuscular quinine in children with severe malaria.

Authors:  S Krishna; N V Nagaraja; T Planche; T Agbenyega; G Bedo-Addo; D Ansong; A Owusu-Ofori; A L Shroads; G Henderson; A Hutson; H Derendorf; P W Stacpoole
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Effect of dose size on the pharmacokinetics of orally administered quinine.

Authors:  A Sowunmi; L A Salako
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

3.  Polymorphisms in Pfmdr1, Pfcrt, and Pfnhe1 genes are associated with reduced in vitro activities of quinine in Plasmodium falciparum isolates from western Kenya.

Authors:  Jelagat Cheruiyot; Luicer A Ingasia; Angela A Omondi; Dennis W Juma; Benjamin H Opot; Joseph M Ndegwa; Joan Mativo; Agnes C Cheruiyot; Redemptah Yeda; Charles Okudo; Peninah Muiruri; Ngalah S Bidii; Lorna J Chebon; Paul O Angienda; Fredrick L Eyase; Jacob D Johnson; Wallace D Bulimo; Ben Andagalu; Hoseah M Akala; Edwin Kamau
Journal:  Antimicrob Agents Chemother       Date:  2014-04-21       Impact factor: 5.191

4.  Intramuscular loading dose of quinine for falciparum malaria: pharmacokinetics and toxicity.

Authors:  Y Wattanagoon; R E Phillips; D A Warrell; K Silamut; S Looareesuwan; B Nagachinta; D J Back
Journal:  Br Med J (Clin Res Ed)       Date:  1986-07-05

5.  The treatment of severe falciparum malaria.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1985-11-30

Review 6.  Drug treatment and prevention of malaria.

Authors:  N J White
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 7.  Science, medicine and clinical pharmacology. The Lilly Lecture 1994.

Authors:  A Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1995-07       Impact factor: 4.335

8.  Disposition of oral quinine in acute falciparum malaria.

Authors:  W Supanaranond; T M Davis; S Pukrittayakamee; K Silamut; J Karbwang; P Molunto; L Chanond; N J White
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

9.  Interspecies allometric scaling of antimalarial drugs and potential application to pediatric dosing.

Authors:  S M D K Ganga Senarathna; Kevin T Batty
Journal:  Antimicrob Agents Chemother       Date:  2014-08-04       Impact factor: 5.191

Review 10.  Antimalarial drugs. An update.

Authors:  D C Warhurst
Journal:  Drugs       Date:  1987-01       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.